Apple Jumps, Goldman Rises, Pfizer Lower After Abandoning Obesity Pill
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On this episode of Stock Movers:
- Apple (AAPL) shares jump on Monday after US President Donald Trump’s administration temporarily exempted phones, computers and chips from its so-called reciprocal tariffs. The exclusions, published late Friday by US Customs and Border Protection, narrow the scope of the levies by excluding the products from Trump’s 125% China tariff and his baseline 10% global tariff on nearly all other countries.
- Goldman Sachs (GS) shares rise after stock traders posted their highest quarterly revenue haul on record, riding a wave of volatility triggered by an emerging global trade war that’s roiled financial markets. Equity-trading revenue rose 27% from a year earlier to $4.19 billion for the first three months of the year, according to a statement Monday.
- Pfizer (PFE) shares edge lower after it halted development of its highest profile experimental drug, an obesity pill aimed at the blockbuster weight-loss market dominated by shots from Novo Nordisk A/S and Eli Lilly & Co., after it was linked to liver damage in a clinical trial.
See omnystudio.com/listener for privacy information.